NYC Confirms First Case of Monkeypox Clade I: Risk Remains Low

by Chief Editor

New York City Confirms First Case of Clade I Monkeypox: What You Need to Know

New York City’s Department of Health and Mental Hygiene has confirmed the first case of Clade I monkeypox (mpox) in the city. The case involves an individual who recently returned from international travel. While health officials are closely monitoring the situation, they emphasize that the risk to the general public remains low.

Understanding the Difference: Clade I vs. Clade II

This isn’t the first time New York City has faced a monkeypox outbreak. But, this case is significant because it involves Clade I, a variant that differs from the Clade II strain responsible for the 2022 outbreak. According to health authorities, Clade I historically presents with more severe symptoms and a higher mortality rate, particularly in Central and West Africa where It’s more commonly found.

Current Situation: No Local Transmission Yet

As of now, no additional cases have been identified, and there is no evidence of local transmission within the five boroughs of New York City. The city’s epidemiological surveillance system is actively tracking potential contacts and monitoring for any signs of community spread. The Department of Health reports that, should the situation remain unchanged, the probability of widespread transmission is minimal.

Symptoms to Watch For

Monkeypox symptoms typically begin with fever, chills, and general malaise, similar to the flu. A hallmark of the infection is a painful rash that can appear on the hands, feet, face, and genital area. The virus spreads through close or intimate contact, including hugging, kissing, and sexual contact.

Pro Tip: If you experience a rash accompanied by fever and flu-like symptoms, especially after recent travel or close contact with someone who may be infected, consult a healthcare professional immediately.

Who Should Receive Vaccinated?

The Department of Health recommends that individuals at higher risk of exposure receive the JYNNEOS vaccine. This includes:

  • Men who have sex with men, including transgender, non-binary, gender fluid, or gender non-conforming individuals.
  • Individuals planning to travel to regions where Clade I monkeypox is actively circulating and anticipate sexual encounters with new partners.
  • Individuals who believe they are at risk of exposure through sexual or other intimate contact.

Those who have already had monkeypox do not need to be vaccinated at this time.

Vaccination Access in New York City

Residents of New York City can access vaccination through the city’s health map, an official government platform, or by calling 311 for information on available locations and appointments. The vaccine is free for prioritized groups.

What is Clade I Monkeypox?

According to the World Health Organization (WHO), Clade I monkeypox, also known as “monkeypox type I,” is less frequently found outside of Central and West Africa, where the majority of outbreaks have historically occurred. The Lancet medical journal notes that this clade has historically been associated with more severe clinical presentations in Central Africa.

Preventive Measures and Ongoing Vigilance

Health officials are emphasizing the importance of continued vigilance and preventive measures. This includes monitoring for new cases, tracing contacts, and promoting vaccination among at-risk populations. The city’s response is coordinated with federal agencies, such as the Centers for Disease Control and Prevention (CDC), to ensure a comprehensive approach.

Frequently Asked Questions (FAQ)

Q: Is the Clade I monkeypox more dangerous than the Clade II strain?
A: Health authorities indicate that Clade I has historically been associated with more severe symptoms and a higher mortality rate, particularly in Central and West Africa.

Q: What should I do if I think I have monkeypox?
A: Consult a healthcare professional immediately if you experience symptoms such as fever, chills, and a painful rash.

Q: Is the JYNNEOS vaccine effective against Clade I?
A: The JYNNEOS vaccine is approved for the prevention of monkeypox and is recommended for individuals at higher risk of exposure.

Q: Where can I find more information about monkeypox in New York City?
A: Visit the New York City Department of Health and Mental Hygiene website or call 311.

Stay informed and protect yourself and your community. For the latest updates and resources, visit the New York City Department of Health website and the CDC website.

You may also like

Leave a Comment